Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Comparison of the performance of the NucliSENS EasyQ HPV E6/E7 mRNA assay and HPV DNA chip for testing squamous cell lesions of the uterine cervix.

Munkhdelger J, Choi Y, Lee D, Kim S, Kim G, Park S, Choi E, Jin H, Jeon BY, Lee H, Park KH.

Diagn Microbiol Infect Dis. 2014 Aug;79(4):422-7. doi: 10.1016/j.diagmicrobio.2014.04.004. Epub 2014 Apr 26.

PMID:
24856365
2.

Human papillomavirus mRNA testing for the detection of anal high-grade squamous intraepithelial lesions in men who have sex with men infected with HIV.

Sendagorta E, Romero MP, Bernardino JI, Beato MJ, Alvarez-Gallego M, Herranz P.

J Med Virol. 2015 Aug;87(8):1397-403. doi: 10.1002/jmv.24188. Epub 2015 May 1.

PMID:
25940055
3.

HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.

Duvlis S, Popovska-Jankovic K, Arsova ZS, Memeti S, Popeska Z, Plaseska-Karanfilska D.

J Med Virol. 2015 Sep;87(9):1578-86. doi: 10.1002/jmv.24199. Epub 2015 Apr 16.

PMID:
25880030
4.

Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.

Wang HY, Park S, Kim S, Lee D, Kim G, Kim Y, Park KH, Lee H.

Am J Clin Pathol. 2015 Mar;143(3):344-51. doi: 10.1309/AJCPF2XGZ2XIQYQX.

PMID:
25696792
5.

Human papillomavirus (HPV) E6/E7 mRNA as a triage test after detection of HPV 16 and HPV 18 DNA.

Perez Castro S, Iñarrea Fernández A, Lamas González MJ, Sarán Diez MT, Cid Lama A, Alvarez Martín MJ, Pato Mosquera M, López-Miragaya I, Estévez N, Torres Piñón J, Oña Navarro M.

J Med Virol. 2013 Jun;85(6):1063-8. doi: 10.1002/jmv.23544.

PMID:
23588733
6.

Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay.

Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, Blanc B.

J Clin Virol. 2010 Feb;47(2):177-81. doi: 10.1016/j.jcv.2009.11.011. Epub 2009 Dec 22.

PMID:
20022804
7.

Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men.

Silling S, Kreuter A, Hellmich M, Swoboda J, Pfister H, Wieland U.

J Clin Virol. 2012 Apr;53(4):325-31. doi: 10.1016/j.jcv.2011.12.029. Epub 2012 Jan 18.

PMID:
22261122
8.
9.

Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.

Tezcan S, Ozgur D, Ulger M, Aslan G, Gurses I, Serin MS, Giray BG, Dilek S, Emekdas G.

Asian Pac J Cancer Prev. 2014;15(9):3997-4003.

10.

Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.

Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C, Griefingholt H, Kovács K, Klozoris C, Bollmann R.

Oncol Rep. 2008 Feb;19(2):457-65.

PMID:
18202795
11.

High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.

Persson M, Brismar Wendel S, Ljungblad L, Johansson B, Weiderpass E, Andersson S.

Oncol Rep. 2012 Jul;28(1):346-52. doi: 10.3892/or.2012.1755. Epub 2012 Apr 3.

PMID:
22484610
12.

Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.

Cattani P, Zannoni GF, Ricci C, D'Onghia S, Trivellizzi IN, Di Franco A, Vellone VG, Durante M, Fadda G, Scambia G, Capelli G, De Vincenzo R.

J Clin Microbiol. 2009 Dec;47(12):3895-901. doi: 10.1128/JCM.01275-09. Epub 2009 Oct 14.

13.

Comparison of the detection of HPV-16, 18, 31, 33, and 45 by type-specific DNA- and E6/E7 mRNA-based assays of HPV DNA positive women with abnormal Pap smears.

Salimović-Bešić I, Tomić-Čiča A, Smailji A, Hukić M.

J Virol Methods. 2013 Dec;194(1-2):222-8. doi: 10.1016/j.jviromet.2013.08.036. Epub 2013 Sep 13.

PMID:
24036071
14.

Performance of the HPV-16 L1 methylation assay and HPV E6/E7 mRNA test for the detection of squamous intraepithelial lesions in cervical cytological samples.

Qiu C, Zhi Y, Shen Y, Gong J, Li Y, Rong S, Okunieff P, Zhang L, Li X.

J Virol Methods. 2015 Nov;224:35-41. doi: 10.1016/j.jviromet.2015.08.008. Epub 2015 Aug 20.

PMID:
26297960
15.

Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.

Ge Y, Christensen P, Luna E, Armylagos D, Schwartz MR, Mody DR.

Cancer Cytopathol. 2017 Aug;125(8):652-657. doi: 10.1002/cncy.21875. Epub 2017 Jun 2.

PMID:
28574670
16.

Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US).

Waldstrom M, Ornskov D.

Cytopathology. 2012 Dec;23(6):389-95. doi: 10.1111/j.1365-2303.2011.00923.x. Epub 2011 Sep 20.

PMID:
21933290
17.

Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.

Benevolo M, Vocaturo A, Caraceni D, French D, Rosini S, Zappacosta R, Terrenato I, Ciccocioppo L, Frega A, Giorgi Rossi P.

J Clin Microbiol. 2011 Jul;49(7):2643-50. doi: 10.1128/JCM.02570-10. Epub 2011 Apr 27.

18.
19.

High Risk HPV E6/E7 Oncoprotein Expression in Women with High Grade Squamous Intraepithelial Lesion.

Valença JE, Gonçalves AK, Guerreiro da Silva ID, Eleutério Junior J, Tenório da Silva T, Bruneska D, Ximenes RA.

Rev Bras Ginecol Obstet. 2016 Mar;38(3):154-9. doi: 10.1055/s-0036-1580713. Epub 2016 Mar 29.

20.

Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.

Liu TY, Xie R, Luo L, Reilly KH, He C, Lin YZ, Chen G, Zheng XW, Zhang LL, Wang HB.

J Virol Methods. 2014 Feb;196:120-5. doi: 10.1016/j.jviromet.2013.10.032. Epub 2013 Nov 9.

PMID:
24216236

Supplemental Content

Support Center